Immunovant, Inc. (IMVT) vs Mirum Pharmaceuticals, Inc. (MIRM)
- Immunovant, Inc. IMVT 26.73 −2.84%
- Mirum Pharmaceuticals, Inc. MIRM 80.18 −2.68%
Immunovant, Inc. and Mirum Pharmaceuticals, Inc. are both Biotechnology companies. Immunovant, Inc. and Mirum Pharmaceuticals, Inc. are of similar size ($5.7B and $5.4B). Immunovant, Inc. has the higher net margin (0.00% vs −139.2%) and the higher return on invested capital (0.00% vs −173.0%). Across the 13 metrics below, Immunovant, Inc. leads on 8 and Mirum Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | IMVT | MIRM | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 81.72% | 65.16% |
| Operating margin | 0.00% | (134.93%) | 0.00% |
| Net margin | 0.00% | (139.18%) | 0.00% |
| Free cash flow margin | 0.00% | (44.29%) | 0.00% |
| Return on equity | (80.10%) | (702.97%) | (56.36%) |
| Return on assets | (71.10%) | (97.15%) | (48.04%) |
| Return on invested capital | 0.00% | (172.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack